ALLERGYPATH LTD.
Summary
ALLERGYPATH LTD. is an active private limited company (company number 16857633) incorporated on 14 November 2025, registered in Marlborough. Its registered activity is business and domestic software development (SIC 62012). No accounts have been filed yet; the first accounts are due by 14 August 2027.
There are 6,222 companies in business and domestic software development in Other with filed accounts; the median reports net assets of £1,000 and is 8 years old.
Key dates
- Incorporated
- 14 November 2025under 1 yr ago
- First accounts due
- 14 August 2027in 296 days
- Confirmation statement due
- 28 November 2026in 37 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 62012
- Business and domestic software development
- SIC 62090
- Other information technology service activities
- SIC 86210
- General medical practice activities
- SIC 86900
- Other human health activities
- Accounts type
- No Accounts Filed
Financials
No accounts filed yet. The first accounts are due by 14 August 2027; this page updates when they are filed.
Ownership and control
- Mr Harry James Bailey
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- First accounts duein 296 days
- Confirmation statement duein 37 days
- Incorporated
Similar companies in the UK
- ESRUCODES LTDGreen Lanes · inc. Nov 2025
- VISIONTRI TECH LTDSwindon · inc. Nov 2025
- GARANTIA PLUS LTDIpswich · inc. Nov 2025
- SIMPLE SOFT SOLUTIONS LTDWorcester · inc. Nov 2025
- REVIEW SENSE AI LIMITEDBury St. Edmunds · inc. Nov 2025
- MY NUTRITION CLUB LIMITEDAberystwyth · inc. Nov 2025
All companies incorporated on 14 November 2025 · in Nov 2025.
Reminders for ALLERGYPATH LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.